More recently, Zhao et al. (Zhao et al., 2016) found progressively increasing levels of total caspase-9 and other pro-apoptotic proteins in platelet rich plasma from patients with amnesic mild cognitive impairment (a loss of cognitive function that can progress to an AD diagnosis) and AD compared to subjects without cognitive deficits. This evidence concerns the gene CASP9 and Alzheimer disease.